02/12 2022 Regulatory New order valued at 15.2 MSEK smashes previous company record Redsense Medical has secured a new order valued at 15.2 MSEK from one of the company’s US distributors. “An order of this magnitude is of… [read more]
15/11 2022 Regulatory Correction: Consolidated cash flow analysis interim report January-September 2022 Redsense Medical AB (publ) The correction refers to the consolidated cash flow analysis on page 13 of the interim report January-September 2022. Corrected report is attached and available on… [read more]
09/11 2022 Regulatory Interim Report Q3 – July – September, 2022 Redsense Medical AB (publ) Focus ahead as US purchasing patterns burden Q3 July – September 2022 · Net sales amounted to kSEK 1,023 (3,566), a decrease of 71.3 percent.… [read more]
